NYSE
6 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.2574 per share on April 21, 2025, according to a Form 4 filing.

NYSE
13 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells Shares of Kellanova (K) Under 10b5-1 Plan
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.4121 per share on April 14, 2025, according to a Form 4 filing.

NYSE
20 days, 13 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.0297 per share on April 7, 2025, according to a Form 4 filing.

NYSE
30 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.4386 per share on March 28, 2025, according to a Form 4 filing.

NYSE
37 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K) Under 10b5-1 Plan
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) common stock at a price of $82.3071 per share on March 21, 2025, according to a Form 4 filing.

NYSE
44 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K) at $82.26
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) common stock at a price of $82.2554 per share on March 14, 2025, reducing its holdings to 47,618,280 shares.

NYSE
46 days, 15 hours ago 
K
Kellanova
8-K: Kellanova Secures Mars Guarantee for Senior Notes Following Merger Consent Solicitations
Kellanova successfully obtains Mars' guarantee for its senior notes through consent solicitations, contingent on the completion of their merger.

NYSE
51 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.5498 per share on March 7, 2025, according to a Form 4 filing.

NYSE
51 days, 15 hours ago 
K
Kellanova
10-K/A: Kellanova Files Amendment to 10-K, Providing Detailed Executive Compensation and Governance Information
Kellanova's amended 10-K filing includes comprehensive details on director and executive compensation, corporate governance practices, and related party transactions for the fiscal year ended December 28, 2024.

NYSE
58 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova common stock at a price of $82.6978 per share on February 28, 2025, according to a Form 4 filing.

NYSE
59 days, 15 hours ago 
K
Kellanova
8-K: Kellanova Announces RSU Grants to Named Executive Officers
Kellanova's Board of Directors approved restricted stock unit (RSU) grants to its named executive officers on February 21, 2025, under the Kellanova 2022 Long-Term Incentive Plan.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Nicolas Amaya Reports Acquisition of Restricted Stock Units
Senior Vice President Nicolas Amaya reports the acquisition of restricted stock units and adjustments to common stock holdings.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Charisse Ford Hughes Reports Acquisition of Restricted Stock Units
Senior Vice President Charisse Ford Hughes reports the acquisition of 9,320 restricted stock units of Kellanova common stock.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Howell Melissa A Reports Acquisition of Restricted Stock Units
Senior Vice President Howell Melissa A reports acquisition of 19,600 restricted stock units in Kellanova.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive David Lawlor Reports Acquisition of Restricted Stock Units
Senior Vice President David Lawlor reports the acquisition of restricted stock units in Kellanova.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Kris Bahner Reports Acquisition of Restricted Stock Units
Kris Bahner, SVP-Chief Global Corporate Affairs at Kellanova, reports the acquisition of 8,720 restricted stock units on February 21, 2025.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Shumit Kapoor Reports Acquisition of Restricted Stock Units
Senior Vice President of Kellanova, Shumit Kapoor, reports the acquisition of 18,880 restricted stock units.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Chairman and CEO Steven Cahillane Reports Acquisition of Restricted Stock Units
Steven Cahillane, Chairman and CEO of Kellanova, reports the acquisition of 118,560 restricted stock units.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Acquires Restricted Stock Units
Senior Vice President Victor Marroquin acquired 8,470 restricted stock units of Kellanova common stock on February 21, 2025, which vest on February 21, 2028.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Amit Banati Reports Stock Transactions
Senior Vice President Amit Banati reports acquisition of restricted stock units and disposal of common stock.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Lance Rodrigo Reports Acquisition of Restricted Stock Units
Senior Vice President Lance Rodrigo reports acquisition of Kellanova restricted stock units and updates beneficial ownership.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Kurt D Forche Reports Acquisition of Restricted Stock Units
Kurt D Forche, VP-Corporate Controller of Kellanova, reports the acquisition of restricted stock units and updates to beneficial ownership of common stock.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Chief Legal Officer Reports Acquisition of Restricted Stock Units
Todd W. Haigh, Chief Legal Officer of Kellanova, reports the acquisition of 17,790 restricted stock units and adjustments to common stock holdings.

NYSE
62 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Amit Banati Reports Stock Transactions
Senior Vice President Amit Banati reports acquisition and disposal of Kellanova common stock and derivative securities, including transactions related to stock options and restricted stock units.

NYSE
62 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Kris Bahner Reports Stock Transactions
Kris Bahner, SVP-Chief Global Corporate Affairs at Kellanova, reports the acquisition and disposal of common stock and derivative securities.

NYSE
62 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Nicolas Amaya Reports Stock Transactions
Nicolas Amaya, a Senior Vice President at Kellanova, reported the acquisition and disposal of company stock and derivative securities.

NYSE
62 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Victor Marroquin Reports Stock Transactions
Senior Vice President Victor Marroquin reports transactions involving Kellanova stock, including the exercise of stock options and restricted stock units, as well as the disposition of shares to cover tax obligations.

NYSE
62 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Chief Legal Officer Reports Stock Transactions
Todd W. Haigh, Chief Legal Officer of Kellanova, reports the acquisition and disposal of common stock and derivative securities.

NYSE
62 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Lance Rodrigo Reports Stock Transactions
Senior Vice President Lance Rodrigo reports exercising stock options and restricted stock units, and disposing of shares to cover taxes.

NYSE
62 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive David Lawlor Reports Stock Transactions
David Lawlor, a Senior Vice President at Kellanova, reported the acquisition and disposal of company stock and derivative securities.

NYSE
62 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Chairman and CEO Steven Cahillane Reports Stock Transactions
Steven Cahillane, Chairman and CEO of Kellanova, reports the vesting and disposal of restricted stock units.

NYSE
62 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Kurt D Forche Reports Stock Transactions
Kellanova's VP-Corporate Controller, Kurt D Forche, reports the disposition of shares to cover tax obligations upon vesting of restricted stock units.

NYSE
62 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Howell Reports Stock Transactions
Melissa A. Howell, Senior Vice President of Kellanova, reports the acquisition and disposal of company stock and restricted stock units on February 21, 2025.

NYSE
62 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Charisse Ford Hughes Reports Stock Transactions
Charisse Ford Hughes, a Senior Vice President at Kellanova, reported the acquisition and disposal of company stock and restricted stock units on February 21, 2025.

NYSE
62 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Shumit Kapoor Reports Stock Unit Transaction
Senior Vice President Shumit Kapoor of Kellanova reports the disposition of 26,401 common stock units on February 21, 2025.

NYSE
65 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.5005 per share on February 21, 2025, according to a Form 4 filing.

NYSE
65 days, 15 hours ago 
K
Kellanova
10-K: Kellanova's 2024 10-K Filing: Merger Pending, Snacks Lead Growth Amidst Macroeconomic Headwinds
Kellanova's 2024 results highlight a pending merger with Mars, a focus on snacks-led growth, and navigation of complex macroeconomic conditions following the spin-off of WK Kellogg Co.
Delay expected
 
Worse than expected
 

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Executive Victor Marroquin Reports Stock Transactions
Senior Vice President Victor Marroquin reports the disposition of Kellanova stock and restricted stock units on February 18, 2025.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Executive Rodrigo Lance Reports Stock Transactions
Senior Vice President Rodrigo Lance reports the vesting and disposal of restricted stock units and shares of Kellanova common stock.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Executive David Lawlor Reports Stock Transactions
David Lawlor, a Senior Vice President at Kellanova, reported the vesting and subsequent disposal of restricted stock units on February 18, 2025.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Shumit Kapoor Reports Stock Transactions
Senior Vice President of Kellanova, Shumit Kapoor, reports the acquisition and disposal of common stock and restricted stock units on February 18, 2025.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Executive Charisse Ford Hughes Reports Stock Transactions
Senior Vice President Charisse Ford Hughes of Kellanova reports the acquisition and disposal of common stock and restricted stock units on February 18, 2025.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Executive Howell Reports Stock Transactions
Senior Vice President Melissa A. Howell of Kellanova reports the vesting and subsequent sale of restricted stock units.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Chief Legal Officer Reports Stock Transactions
Todd W. Haigh, Chief Legal Officer of Kellanova, reports the acquisition and disposal of company stock and restricted stock units on February 18, 2025.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova VP-Corporate Controller Kurt D Forche Reports Stock Transactions
Kurt D Forche, VP-Corporate Controller of Kellanova, reports the acquisition and disposal of common stock and restricted stock units on February 18, 2025.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Chairman and CEO Steven Cahillane Reports Stock Transactions
Steven Cahillane, Chairman and CEO of Kellanova, reports the acquisition and disposal of company stock and restricted stock units on February 18, 2025.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Amit Banati Reports Stock Transactions
Senior Vice President Amit Banati of Kellanova reports the acquisition and disposal of common stock and restricted stock units on February 18, 2025.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova SVP-Chief Global Corp Affairs, Kris Bahner, Reports Stock Transactions
Kris Bahner, SVP-Chief Global Corp Affairs at Kellanova, reports the vesting and subsequent sale of restricted stock units.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Executive Nicolas Amaya Reports Stock Transactions
Senior Vice President Nicolas Amaya reports the acquisition and disposal of Kellanova common stock and restricted stock units on February 18, 2025.

NYSE
72 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.2528 per share on February 14, 2025, according to a Form 4 filing.

NYSE
72 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Director Stephanie Burns Reports Changes in Beneficial Ownership
Director Stephanie Burns reports a transaction involving phantom stock units and indirect ownership of common stock in Kellanova.

NYSE
72 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Director Gund Reports Changes in Beneficial Ownership
Director G. Zachary Gund reports changes in beneficial ownership of Kellanova shares, including acquisitions of phantom stock units and holdings in various trusts and partnerships.

NYSE
76 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.2309 per share on February 10, 2025, according to a Form 4 filing.

NYSE
80 days, 23 hours ago 
K
Kellanova
8-K: Kellanova Reports Strong Q4 and Full Year 2024 Results Amidst Pending Mars Acquisition
Kellanova announced strong fourth quarter and full year 2024 results, marked by organic growth and improved profitability, while preparing for its acquisition by Mars, Incorporated.
Better than expected
 

NYSE
89 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $81.9092 per share on January 28, 2025, according to a Form 4 filing.

NYSE
96 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $81.6862 per share on January 21, 2025, according to a Form 4 filing.

NYSE
103 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova
The Kellogg W K Foundation Trust sold 114,583 shares of Kellanova stock at a price of $81.4214 per share on January 14, 2025.

NYSE
110 days, 13 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova stock at a price of $81.2809 per share on January 7, 2025.

NYSE
118 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.8464 per share on December 30, 2024, according to a Form 4 filing with the SEC.

NYSE
125 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells Shares of Kellanova (K) Under 10b5-1 Plan
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.6424 per share on December 23, 2024, according to a Form 4 filing.

NYSE
132 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The Kellogg W K Foundation Trust sold 114,583 shares of Kellanova stock at a price of $80.6892 per share on December 16, 2024.

NYSE
136 days, 15 hours ago 
K
Kellanova
8-K: Kellanova Secures $750 Million Credit Facility, Replacing Existing Agreement
Kellanova has entered into a new $750 million unsecured 364-Day Credit Agreement, replacing its previous facility and providing funds for general corporate purposes.

NYSE
139 days, 13 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova stock at a price of $80.6986 per share on December 9, 2024.

NYSE
149 days, 17 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The Kellogg W K Foundation Trust sold 114,583 shares of Kellanova stock at a price of $81.2129 per share on November 29, 2024.

NYSE
157 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The Kellogg W K Foundation Trust sold 114,583 shares of Kellanova stock at a price of $80.9916 per share on November 21, 2024.

NYSE
160 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Executive Kris Bahner Reports Stock Transactions
Kellanova's SVP-Chief Global Corporate Affairs, Kris Bahner, reported the acquisition and disposal of company stock and restricted stock units on November 16, 2024.

NYSE
164 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The Kellogg W K Foundation Trust sold 114,583 shares of Kellanova stock at a price of $81.0448 per share.

NYSE
164 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Director Stephanie Burns Reports Acquisition of Phantom Stock Units
Director Stephanie Burns of Kellanova reported the acquisition of 162.82 phantom stock units, as well as holding 31,293.436 common shares in trust.

NYSE
164 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Director G. Zachary Gund Reports Acquisition of Phantom Stock Units
Director G. Zachary Gund reported the acquisition of 325.64 phantom stock units in Kellanova, along with holdings of common stock through various trusts and partnerships.

NYSE
171 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.8862 per share on November 7, 2024, according to a Form 4 filing with the SEC.

NYSE
175 days, 1 hours ago 
K
Kellanova
8-K: Kellanova Shareowners Approve Merger with Acquiror 10VB8, LLC
Kellanova shareholders have approved the merger agreement with Acquiror 10VB8, LLC, paving the way for the company to become a wholly-owned subsidiary.

NYSE
179 days, 0 hours ago 
K
Kellanova
10-Q: Kellanova Reports Q3 2024 Results Amidst Proposed Merger
Kellanova's Q3 2024 results show a slight decrease in net sales but an increase in operating profit, while the company navigates a proposed merger with Mars, Incorporated.
Better than expected
 
Delay expected
 

NYSE
179 days, 0 hours ago 
K
Kellanova
DEFA14A: Kellanova Reports Strong Q3 Results Amidst Pending Acquisition by Mars
Kellanova announced strong third-quarter results, driven by organic growth and improved profitability, while awaiting shareholder approval for its acquisition by Mars, Incorporated.
Better than expected
 

NYSE
179 days, 0 hours ago 
K
Kellanova
8-K: Kellanova Reports Strong Q3 Results Amidst Pending Mars Acquisition
Kellanova announced strong third-quarter results for 2024, marked by double-digit operating profit and earnings per share growth, while a merger with Mars, Incorporated is pending.
Better than expected
 

NYSE
181 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.7609 per share on October 28, 2024, according to a Form 4 filing.

NYSE
188 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.9598 per share on October 21, 2024, according to a Form 4 filing.

NYSE
188 days, 16 hours ago 
K
Kellanova
DEFA14A: Kellanova Addresses Lawsuits and Demand Letters Related to Mars Merger with Supplemental Disclosures
Kellanova is supplementing its definitive proxy statement with additional disclosures to address claims made in lawsuits and demand letters regarding the proposed merger with Mars, Incorporated.

NYSE
188 days, 16 hours ago 
K
Kellanova
8-K: Kellanova Amends Proxy Statement Following Merger Lawsuits and Shareholder Demands
Kellanova has supplemented its definitive proxy statement related to its merger with Acquiror 10VB8, LLC, following lawsuits and demand letters from shareholders alleging misrepresentations and omissions.
Worse than expected
 

NYSE
194 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.6254 per share on October 14, 2024, according to a Form 4 filing.

NYSE
198 days, 16 hours ago 
K
Kellanova
DEFA14A: Kellanova Urges Stockholders to Vote on Proposed Merger
Kellanova is soliciting proxies for a special meeting of stockholders to approve a proposed merger, with voting directions due by October 29, 2024.

NYSE
202 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.5651 per share on October 7, 2024, according to a Form 4 filing with the SEC.

NYSE
205 days, 15 hours ago 
K
Kellanova
DEFA14A: Kellanova Special Meeting Set for November 1, 2024, to Vote on Proposed Merger with Mars
Kellanova has scheduled a special meeting on November 1, 2024, for stockholders to vote on the proposed merger with Mars.

NYSE
209 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.7196 per share on September 30, 2024, according to a Form 4 filing with the SEC.

NYSE
213 days, 16 hours ago 
K
Kellanova
DEFM14A: Kellanova Shareowners to Vote on $83.50 Per Share Merger Agreement with Mars, Incorporated
Kellanova's shareowners are set to vote on a proposed merger agreement with Mars, Incorporated, where each share will be acquired for $83.50 in cash.

NYSE
216 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.6845 per share on September 23, 2024, according to a Form 4 filing with the SEC.

NYSE
223 days, 15 hours ago 
K
Kellanova
DEFA14A: Kellanova CEO Visits Mars, Highlights Synergies Ahead of Proposed Acquisition
Kellanova's CEO, Steve Cahillane, visited Mars' offices to discuss the proposed acquisition and potential synergies between the two companies.

NYSE
223 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.6548 per share on September 16, 2024, according to a Form 4 filing.

NYSE
227 days, 16 hours ago 
K
Kellanova
DEFA14A: Mars to Acquire Kellanova for $35.9 Billion, Uniting Snacking Giants
Mars, Incorporated has agreed to acquire Kellanova for $83.50 per share in cash, a deal valued at $35.9 billion, aiming to create a leading snacking business.

NYSE
230 days, 13 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.2508 per share on September 9, 2024, according to a Form 4 filing with the SEC.

NYSE
230 days, 15 hours ago 
K
Kellanova
DEFA14A: Mars to Acquire Kellanova's Snacking Business in $33 Billion Deal
Kellanova's snacking business is set to be acquired by Mars, Inc., creating a world-class snacking business with a combined value of approximately $33 billion.

NYSE
242 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $80.6196 per share on August 28, 2024, according to a Form 4 filing.

NYSE
244 days, 15 hours ago 
K
Kellanova
DEFA14A: Mars to Acquire Kellanova in $50 Billion Deal, Shaping the Future of Snacking
Mars, Incorporated will acquire Kellanova in a transaction expected to close in the first half of 2025, aiming to combine complementary strengths in geography and product categories.

NYSE
249 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $80.3226 per share on August 21, 2024, according to a Form 4 filing with the SEC.

NYSE
251 days, 15 hours ago 
K
Kellanova
DEFA14A: Mars to Acquire Kellanova in $35.9 Billion Deal, Shaping the Future of Snacking
Mars, Incorporated has agreed to acquire Kellanova for $83.50 per share in cash, totaling $35.9 billion, aiming to create a global snacking leader.

NYSE
255 days, 15 hours ago 
K
Kellanova
DEFA14A: Kellanova Addresses Facility Concerns Amid Mars Acquisition
Kellanova attempts to reassure stakeholders regarding facility closures and job security following the announcement of its acquisition by Mars, Inc.

NYSE
256 days, 15 hours ago 
K
Kellanova
DEFA14A: Mars, Incorporated to Acquire Kellanova in $35.9 Billion Deal, Shaping the Future of Snacking
Mars, Incorporated and Kellanova have entered into a definitive agreement for Mars to acquire Kellanova for $83.50 per share in an all-cash transaction valued at $35.9 billion, creating a global snacking powerhouse.
Better than expected
 

NYSE
256 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $80.0452 per share on August 14, 2024, according to a Form 4 filing with the SEC.

NYSE
256 days, 16 hours ago 
K
Kellanova
DEFA14A: Kellanova to Merge with Mars, Inc. in Landmark Deal
Kellanova (formerly Kellogg) is set to merge with Mars, Incorporated, pending stockholder and regulatory approvals, becoming a wholly-owned subsidiary of Acquiror 10VB8, LLC.

NYSE
256 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Gund Reports Changes in Beneficial Ownership
Director Zachary Gund reports changes in beneficial ownership of Kellanova shares, including acquisitions of phantom stock units and holdings through various trusts and partnerships.

NYSE
256 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Stephanie Burns Reports Changes in Beneficial Ownership
Director Stephanie Burns reports changes in beneficial ownership of Kellanova shares, including phantom stock units, as of August 14, 2024.

NYSE
257 days, 1 hours ago 
K
Kellanova
DEFA14A: Mars to Acquire Kellanova for $35.9 Billion, Uniting Snacking and Food Giants
Mars, Incorporated will acquire Kellanova in an all-cash transaction valued at $35.9 billion, combining iconic snacking and food brands to create a global leader.
Capital raise
 

NYSE
257 days, 1 hours ago 
K
Kellanova
8-K: Mars to Acquire Kellanova for $35.9 Billion, Uniting Iconic Snacking and Food Brands
Mars, Incorporated has agreed to acquire Kellanova for $83.50 per share in cash, a deal valued at $35.9 billion, including assumed net leverage.
Better than expected
 

NYSE
263 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $74.0084 per share on August 7, 2024, according to a Form 4 filing with the SEC.

NYSE
269 days, 16 hours ago 
K
Kellanova
10-Q: Kellanova Reports Mixed Q2 Results Amidst Restructuring and Currency Headwinds
Kellanova's second-quarter results show a mix of organic sales growth and currency-related challenges, alongside strategic restructuring efforts.
Better than expected
 

NYSE
270 days, 0 hours ago 
K
Kellanova
8-K: Kellanova Exceeds Expectations in Q2, Raises Full-Year Outlook
Kellanova reported strong second-quarter results, driven by organic growth and improved profitability, leading to an increased full-year outlook.
Better than expected
 

NYSE
272 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Kellanova Shares
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $57.2346 per share on July 29, 2024, according to a Form 4 filing.

NYSE
279 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $57.6656 per share on July 22, 2024, according to a Form 4 filing with the SEC.

NYSE
286 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $56.1945 per share on July 15, 2024, according to a Form 4 filing.

NYSE
293 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $56.1364 per share on July 8, 2024, according to a Form 4 filing with the SEC.

NYSE
303 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $57.6425 per share on June 28, 2024, according to a Form 4 filing.

K 
Kellanova 
NYSE

10-Q: Kellanova Reports Mixed Q2 Results Amidst Restructuring and Currency Headwinds

Sentiment:
 Quarterly Report
 1 August 2024 4:15 PM

Kellanova's second-quarter results show a mix of organic sales growth and currency-related challenges, alongside strategic restructuring efforts.

Better than expected
  The company's operating profit increased by 18% year-over-year, indicating better than expected profitability.  Currency-neutral adjusted operating profit increased by 16%, showing better than expected operational performance.  Diluted EPS increased by 17.6% to $1.00, and currency-neutral adjusted diluted EPS increased by 14.4% to $1.03, both better than expected. 

Summary
  • Kellanova's net sales decreased by 5% year-over-year to $3.192 billion in the second quarter of 2024, primarily due to unfavorable foreign currency impacts and the divestiture of the Russian business.
  • However, organic net sales, which exclude currency and divestiture impacts, increased by 4%.
  • The company's reported operating profit increased by 18% to $493 million, driven by a favorable swing in mark-to-market adjustments, improved gross profit margins, and reimbursements for transition services provided to WK Kellogg Co.
  • Currency-neutral adjusted operating profit increased by 16%, excluding the impact of mark-to-market, network optimization costs, separation costs, and foreign currency translation.
  • Reported diluted earnings per share (EPS) increased by 17.6% to $1.00, while currency-neutral adjusted diluted EPS increased by 14.4% to $1.03.
  • The company is undergoing restructuring programs, including a reconfiguration of the North America frozen supply chain network and the European cereal supply chain network, which are expected to drive future efficiencies and cost savings.
  • Kellanova's net debt stands at $5.591 billion as of June 29, 2024.
  • Free cash flow for the year-to-date period was $443 million, up from $305 million in the prior year.
Sentiment

Score: 6

Explanation: The document presents a mixed picture with positive organic growth and improved profitability offset by currency headwinds and restructuring costs. The company is taking steps to improve its operations, but there are still risks and challenges ahead.

Highlights
  • Organic net sales increased by 4% in Q2 2024, indicating underlying growth despite currency headwinds.
  • Reported operating profit rose by 18% year-over-year, driven by improved margins and transition service reimbursements.
  • Currency-neutral adjusted operating profit increased by 16%, showcasing strong operational performance.
  • Diluted EPS increased by 17.6% to $1.00, and currency-neutral adjusted diluted EPS increased by 14.4% to $1.03.
  • The company is actively restructuring its North America and European supply chains, with expected cost savings in the coming years.
  • Kellanova has a $1.3 billion share repurchase authorization remaining through December 2025.
  • The company expects to generate $1.7 billion of operating cash flow during 2024.
Positives
  • Kellanova experienced a 4% increase in organic net sales, demonstrating solid underlying business growth.
  • The company's operating profit saw an 18% increase, indicating improved profitability.
  • Currency-neutral adjusted operating profit grew by 16%, highlighting strong operational performance.
  • Diluted EPS and currency-neutral adjusted diluted EPS both showed double-digit growth.
  • The company is actively pursuing restructuring initiatives to enhance efficiency and reduce costs.
  • Kellanova has a strong cash flow generation capability, with $1.7 billion expected in 2024.
  • The company has access to $2.5 billion in unused revolving credit agreements.
Negatives
  • Reported net sales decreased by 5% due to unfavorable foreign currency impacts and the divestiture of the Russian business.
  • The Nigerian Naira devaluation significantly impacted AMEA segment sales and profitability.
  • The company incurred $109 million in restructuring charges year-to-date, primarily related to severance and asset impairment.
  • Europe segment net sales decreased by 4.5% due to volume pressures and the divestiture of the Russian business.
  • The company has a negative working capital of $1.3 billion as of June 29, 2024.
Risks
  • Unfavorable foreign currency exchange rates, particularly the devaluation of the Nigerian Naira, continue to negatively impact reported sales and profitability.
  • The company faces risks associated with the implementation of its restructuring programs, including potential delays and higher-than-expected costs.
  • The company's reliance on supplier finance programs and monetization programs exposes it to potential risks if financial institutions terminate their participation.
  • Geopolitical instability and economic conditions could lead to market disruptions, supply chain challenges, and inflationary pressures.
  • Changes in consumer behavior and preferences could impact the demand for Kellanova's products.
  • The company has a substantial amount of indebtedness which results in current maturities of long-term debt and notes payable which can have a significant impact on working capital.
Future Outlook

Kellanova expects to generate $1.7 billion of operating cash flow during 2024 and anticipates cost savings from its restructuring programs to contribute to gross margin improvements in the coming years. The company expects input cost inflation to be flat during 2024.

Management Comments
  • Management consistently utilizes a combination of GAAP and non-GAAP financial measures to evaluate business results.
  • Management believes the presentation of both GAAP and non-GAAP financial measures provides investors with increased transparency.
  • Management uses non-GAAP measures to evaluate the effectiveness of initiatives behind net sales growth, pricing realization, and the impact of mix on business results.
  • Management uses non-GAAP financial measures to evaluate the effectiveness of initiatives intended to improve profitability.
Industry Context

Kellanova's performance is being impacted by broader industry trends such as currency fluctuations, supply chain challenges, and inflationary pressures. The company's restructuring efforts and focus on organic growth are in line with strategies employed by other large consumer goods companies to navigate these challenges. The separation from WK Kellogg Co is a significant strategic move to focus on its core snacks and international business.

Comparison to Industry Standards
  • Kellanova's organic sales growth of 4% is a positive sign, but it is important to compare this to the performance of its direct competitors in the snacks and convenience foods sectors, such as Mondelez, PepsiCo, and General Mills.
  • The company's operating profit margin improvement is a key indicator of its operational efficiency, and should be benchmarked against industry averages and the performance of its peers.
  • The restructuring initiatives are similar to those undertaken by other large food companies to streamline operations and reduce costs, but the success of these initiatives will depend on their effective implementation.
  • The impact of currency fluctuations on Kellanova's results is a common challenge for multinational companies, and its ability to mitigate these impacts will be a key factor in its future performance.
  • The company's net debt of $5.591 billion should be compared to its peers to assess its financial leverage and risk profile.
Stakeholder Impact
  • Shareholders will be impacted by the company's financial performance, restructuring efforts, and dividend payments.
  • Employees will be affected by the restructuring programs, including potential job losses and changes in work locations.
  • Customers may experience changes in product availability and pricing due to supply chain adjustments.
  • Suppliers may be impacted by changes in payment terms and the company's supplier finance programs.
  • Creditors will be impacted by the company's debt levels and ability to meet its obligations.
Next Steps
  • The company will continue to implement its restructuring programs in North America and Europe.
  • Kellanova will focus on driving organic growth and improving profitability.
  • The company will monitor and manage the impact of currency fluctuations.
  • Kellanova will continue to evaluate and optimize its supply chain.
  • The company will continue to assess its supplier payment terms and monetization programs.
Related Party Transactions
  • Kellanova has a Transition Services Agreement (TSA) with WK Kellogg Co, where Kellanova provides certain services and receives reimbursements.
  • Kellanova continues to supply certain inventory to WKKC under a Supply Agreement.
Key Dates
  • 2022-12-31: Board of Directors approved an authorization to repurchase up to $1.5 billion of common stock through December 2025.
  • 2023-07-01: Comparative period end date for financial results.
  • 2023-09-29: Date of the original Supply Agreement with WK Kellogg Co.
  • 2023-10-02: Kellanova completed the spin-off of its North American cereal business.
  • 2024-06-01: Effective date of the Amendment to the Supply Agreement with WK Kellogg Co.
  • 2024-06-29: End date of the reporting period for the second quarter of 2024.
  • 2024-09-03: Shareholders of record date for the dividend declared in July 2024.
  • 2024-09-13: Payment date for the dividend declared in July 2024.
Keywords
Kellanova, Net Sales, Operating Profit, EPS, Restructuring, Supply Chain, Currency Impact, Organic Growth, Financial Results, Consumer Goods

K 
Kellanova 
NYSE
Sector: TBD
 
Filings with Classifications
Delay expected
21 February 2025 4:16 PM

Annual Results
  • The exact timing of the completion of the Merger, if at all, cannot be predicted with any certainty.
Worse than expected
21 February 2025 4:16 PM

Annual Results
  • Net sales decreased 2.8% year-over-year, indicating a decline in overall revenue.
Better than expected
6 February 2025 8:02 AM

Earnings Release
  • The company's organic growth exceeded expectations.
  • Profit margins improved faster than anticipated.
  • Earnings per share showed double-digit growth.
Better than expected
31 October 2024 8:10 AM

Quarterly Report
  • The company's operating profit increased by 10% year-over-year, indicating better than expected profitability.
  • Diluted EPS increased by 84% to $1.05, showing better than expected earnings.
  • Currency-neutral adjusted operating profit increased by 19%, demonstrating better than expected underlying performance.
Delay expected
31 October 2024 8:10 AM

Quarterly Report
  • The merger with Mars is expected to close in the first half of 2025, but the exact timing cannot be predicted with certainty, indicating a potential delay.
Better than expected
31 October 2024 8:09 AM

Financial News Release
  • Kellanova's Q3 results exceeded expectations with double-digit operating profit growth and strong earnings per share growth.
  • Organic net sales growth of 6.1% surpassed the company's long-term target range.
Better than expected
31 October 2024 8:08 AM

Quarterly Report
  • The company's organic net sales growth of 6.1% exceeded expectations.
  • The company's double-digit operating profit growth was better than expected.
  • The company's earnings per share growth was better than expected.
Worse than expected
21 October 2024 4:14 PM

Merger Update
  • The document indicates that the company is facing lawsuits and demand letters, which suggests that the initial proxy statement was not well-received by some shareholders.
  • The need for supplemental disclosures implies that the initial disclosures were inadequate or misleading, which is a negative development.
Better than expected
14 August 2024 5:11 PM

Merger Announcement
  • The acquisition price of $83.50 per share represents a significant premium over the recent trading price of Kellanova stock, indicating a better-than-expected outcome for shareholders.
Capital raise
14 August 2024 7:32 AM

Merger Announcement
  • Mars intends to fully finance the acquisition through a combination of cash-on-hand and new debt, for which commitments have been secured.
Better than expected
14 August 2024 7:25 AM

Merger Announcement
  • The acquisition price represents a significant premium over Kellanova's recent trading price, indicating a better than expected outcome for shareholders.
Better than expected
1 August 2024 4:15 PM

Quarterly Report
  • The company's operating profit increased by 18% year-over-year, indicating better than expected profitability.
  • Currency-neutral adjusted operating profit increased by 16%, showing better than expected operational performance.
  • Diluted EPS increased by 17.6% to $1.00, and currency-neutral adjusted diluted EPS increased by 14.4% to $1.03, both better than expected.
Better than expected
1 August 2024 8:03 AM

Quarterly Report
  • Kellanova's results exceeded expectations due to strong organic growth, improved profitability, and increased full-year guidance.
Capital raise
16 May 2024 4:31 PM

Debt Offering Announcement
  • Kellanova raised $300 million through the issuance of 5.750% Senior Notes due 2054.
  • Kellanova also raised 300 million through the issuance of 3.750% Senior Notes due 2034.
Capital raise
9 May 2024 4:59 PM

Debt Offering Announcement
  • Kellanova raised $600 million through the issuance of senior notes.
  • The offering was split between $300 million in USD denominated notes and 300 million in EUR denominated notes.
Better than expected
2 May 2024 4:13 PM

Quarterly Report
  • The company's currency-neutral adjusted operating profit increased by 30%, indicating better than expected operational performance.
  • Currency-neutral adjusted diluted EPS grew by 33%, reflecting better than expected earnings growth.
Better than expected
2 May 2024 8:02 AM

Quarterly Report
  • The company's adjusted operating profit and earnings per share growth exceeded expectations, driven by improved profit margins and effective cost management.
  • The company's free cash flow generation was significantly better than the prior year, indicating improved financial health.
  • The company's reaffirmation of full-year guidance, despite adverse currency movements, suggests confidence in its underlying performance.
Better than expected
20 February 2024 4:20 PM

Annual Results
  • The company's organic net sales growth of 8.3% exceeded expectations.
  • The company's operating profit increased by 24.3%, indicating better than expected profitability.
  • The company's currency-neutral adjusted diluted EPS of $3.18 was better than expected.
Delay expected
20 February 2024 4:20 PM

Annual Results
  • The document mentions that supply pressures are generally decreasing, though weather and geopolitical issues are resulting in other disruptions and logistical delays into 2024.
Better than expected
8 February 2024 8:06 AM

Quarterly Report
  • The company's fourth-quarter results exceeded previous guidance for net sales, operating profit, and earnings per share.

Disclaimer: This summary was generated by artificial intelligence and its accuracy is not guaranteed. The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.